Match tier Likely match
Presence Current · Arkansas
Last published 2025
Sources OpenAlex · ORCID
Refreshed 2026-08-15
Igor P. Pogribny profile photo

Igor P. Pogribny

This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.

◆ ARA Academy High Impact

Researcher

Also affiliated: University of Lethbridge (2004–2010); University of North Carolina at Chapel Hill (2014); Louisiana State University (1999); Roswell Park Comprehensive Cancer Center (2008); Arkansas Children's Hospital (1999); Russian Academy of Sciences (2004); United States Food and Drug Administration (2004–2022); Heidelberg University (2004); Saginaw Valley State University (1999); Biochemical Society (2012–2015); Veterans Health Administration (2004); University Hospital Heidelberg (2004); Jackson Memorial Hospital (2008); In-Q-Tel (2010); Central Arkansas Veterans Healthcare System (2011); Texas A&M Health Science Center (2017); R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology (2008); Vavilov Institute of General Genetics (2004); Centre international de recherche sur le cancer (2018); The Ohio State University (2006); University of Tennessee at Knoxville (2006); Texas A&M University (2017)

Faculty Researcher

76 h-index 293 pubs 18,121 cited

  • Animals
  • DNA Methylation
  • Male
  • Humans
  • Epigenesis, Genetic
  • Liver
  • Mice
  • Female
  • Rats
  • DNA Damage
  • Gene Expression Regulation, Neoplastic
  • Liver Neoplasms
  • MicroRNAs
  • Histones
  • Carcinoma, Hepatocellular

Biography and Research Information

OverviewAI-generated summary

Igor P. Pogribny's research focuses on the molecular mechanisms underlying chemical-induced toxicity and carcinogenesis, with a particular emphasis on epigenetic alterations. His work investigates how environmental and occupational chemical carcinogens impact DNA methylation, gene expression, and overall cellular processes. Pogribny has published extensively on these topics, with notable contributions to understanding the role of epigenetic changes in the development of liver diseases, including hepatocellular carcinoma and non-alcoholic fatty liver disease.

His laboratory utilizes various animal models, including mice and rats, as well as model organisms like *Caenorhabditis elegans*, to assess the effects of specific chemicals. Recent studies have explored the impact of dietary factors, such as methionine levels and structured lipids, on epigenetic modifications and carcinogenesis. Pogribny also examines the effects of heavy metals like arsenic and mercury on biological systems. His research is supported by a strong publication record, with a high h-index of 76 and over 18,000 citations, underscoring his significant contributions to the field of toxicology.

Metrics

  • h-index: 76
  • Publications: 293
  • Citations: 18,121

Selected Publications

  • AMPK‐Dependent Epigenetic Regulation of Metabolism Mediates the Anti‐Cancer Action of Pterostilbene in Hepatocellular Carcinoma (2025)
    3 citations DOI OpenAlex
  • Mediation analysis of the molecular phenotypes in a severe MASH-like liver injury mouse model (2025)
  • Signature gene expression model for quantitative evaluation of MASH-like liver injury in mice (2025)
    1 citation DOI OpenAlex
  • A preclinical model of severe NASH-like liver injury by chronic administration of a high-fat and high-sucrose diet in mice (2024)
    3 citations DOI OpenAlex
  • Cellular and molecular alterations in a human hepatocellular in vitro model of nonalcoholic fatty liver disease development and stratification (2023)
    1 citation DOI OpenAlex
  • Abstract 6017: Exposure-related DNA methylation and gene expression changes in mammary glands of Sprague Dawley rats treated with lorcaserin (2023)
  • Effect of an obesogenic high-fat and high-sucrose diet on hepatic gene expression signatures in male Collaborative Cross mice (2023)
    4 citations DOI OpenAlex
  • Lipidomic profiling of the hepatic esterified fatty acid composition in diet-induced nonalcoholic fatty liver disease in genetically diverse Collaborative Cross mice (2022)
    The Journal of Nutritional Biochemistry 11 citations DOI OpenAlex
  • Assessment of the effects of organic vs. inorganic arsenic and mercury in Caenorhabditis elegans (2022)
    Current Research in Toxicology 26 citations DOI OpenAlex
  • Epigenetic aberrations of gene expression in a rat model of hepatocellular carcinoma (2022)
    Epigenetics 11 citations DOI OpenAlex
  • Non-alcoholic fatty liver disease-associated DNA methylation and gene expression alterations in the livers of Collaborative Cross mice fed an obesogenic high-fat and high-sucrose diet (2022)
    Epigenetics 11 citations DOI OpenAlex
  • Epigenetic changes induced in mice liver by methionine-supplemented and methionine-deficient diets (2022)
    Food and Chemical Toxicology 12 citations DOI OpenAlex
  • Erratum to: Butyrate-containing structured lipids act on HDAC4, HDAC6, DNA damage and telomerase activity during promotion of experimental hepatocarcinogenesis (2021)
    2 citations DOI OpenAlex
  • Epigenetic alterations induced by genotoxic occupational and environmental human chemical carcinogens: An update of a systematic literature review (2021)
    Mutation Research/Reviews in Mutation Research 35 citations DOI OpenAlex
  • The DEN and CCl<sub>4</sub>‐Induced Mouse Model of Fibrosis and Inflammation‐Associated Hepatocellular Carcinoma (2021)
    Current Protocols 43 citations DOI OpenAlex

View all publications on OpenAlex →

ARA Academy 2023 ARA Fellow

Dr. Pogribny is a distinguished scientist specializing in molecular toxicology and carcinogenesis. He earned his M.D. with honors from Ivano-Frankivsk National Medical University in Ukraine and a Ph.D. in Biochemistry/Oncology from Kyiv National Medical University. Since 2003, he has served as a research biologist and senior biomedical researcher at NCTR.

Policy Impact

Distinguished federal scientist at NCTR advancing understanding of chemical carcinogenesis, supporting the FDA's regulatory mission and public health protection from Arkansas.

Growth Areas

['Population Health Innovations & Clinical Research']

Collaboration Network

63 Collaborators 22 Institutions 7 Countries

Top Collaborators

View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics